Pilot Study Evaluating Safety & Efficacy of DCBT: NiCord® & UNM CBU to Patients With Hematological Malignancies

Clinical trial NCT01221857 · COMPLETED

Trial details

NCT number: NCT01221857
Sponsor: Gamida Cell ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)Non-Hodgkin's Lymphoma Hodgkin's Disease

Start date: 2010-11-01
Primary completion: 2012-09-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.